Literature DB >> 24324979

A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

David H Adler1, Fatima Laher, Erica Lazarus, Katherine Grzesik, Glenda E Gray, Bruce Allan, Anna-Lise Williamson.   

Abstract

BACKGROUND: Self-sampling for Human Papillomavirus (HPV) testing may offer improved patient acceptability, decreased cost, and greater practicality than clinician collection of specimens. HPV testing among adolescents is necessary to conduct vaccine surveillance and may play a role in cervical cancer screening among some populations.
METHODS: A cross-sectional prevalence study was conducted to compare the results of self-collected and clinician-collected specimens for Human papillomavirus (HPV) testing among South African adolescent females. All participants provided self-sampled vaginal swabs and underwent clinician-collection of cervical swabs for HPV DNA analysis. The level of agreement between HPV DNA results from the two specimen collection methods was measured.
RESULTS: The level of agreement between HPV DNA results from self-collected and clinician-collected specimens was high (κ=86.7; p<0.001). A high prevalence of HPV overall was found by both specimen collection methods (57%; 95% CI 0.37-0.75). Low-risk HPV (LR-HPV) types were found slightly more frequently in self-collected specimens.
CONCLUSION: There is a high level of agreement between the HPV DNA results from self-collected and clinician-collected specimens. Self-collection of specimens for HPV testing is a viable alternative among adolescents.

Entities:  

Keywords:  Adolescent; Cervical cancer prevention; Human papillomavirus; Self-sampling; South Africa

Year:  2013        PMID: 24324979      PMCID: PMC3855317          DOI: 10.4172/2329-9541.1000113

Source DB:  PubMed          Journal:  J Immunol Tech Infect Dis


  25 in total

1.  Is it time to introduce HPV self-sampling for primary cervical cancer screening?

Authors:  Patrick Petignat; Pierre Vassilakos
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

2.  ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.

Authors: 
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

3.  Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening.

Authors:  Heidi E Jones; Maarten A H M Wiegerinck; Theodoor E Nieboer; Ben W Mol; Carolyn L Westhoff
Journal:  Sex Transm Dis       Date:  2008-11       Impact factor: 2.830

Review 4.  Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.

Authors:  Lea E Widdice; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-07-23       Impact factor: 5.012

5.  Comparison of type-specific human papillomavirus data from self and clinician directed sampling.

Authors:  Susie Baldwin; Carlos Santos; Elena Mendez Brown; Thomas Nuño; Anna Giuliano; John Davis; Francisco Garcia
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

6.  Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities.

Authors:  Sarah Igidbashian; Sara Boveri; Noemi Spolti; Davide Radice; Maria Teresa Sandri; Mario Sideri
Journal:  J Womens Health (Larchmt)       Date:  2011-02-25       Impact factor: 2.681

7.  Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.

Authors:  Patrick Petignat; Catherine Hankins; Sharon Walmsley; Deborah Money; Diane Provencher; Karina Pourreaux; Janet Kornegay; Fabrice Rouah; François Coutlée
Journal:  Clin Infect Dis       Date:  2005-07-14       Impact factor: 9.079

8.  Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus.

Authors:  Jessica A Kahn; Gail B Slap; Bin Huang; Susan L Rosenthal; Abbigail M Wanchick; Linda M Kollar; Paula A Hillard; David Witte; Pam Groen; David I Bernstein
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

9.  A comparison of cervical and vaginal human papillomavirus.

Authors:  Philip E Castle; Ana C Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

10.  Monitoring human papillomavirus prevalence in urine samples: a review.

Authors:  Espen Enerly; Cecilia Olofsson; Mari Nygård
Journal:  Clin Epidemiol       Date:  2013-03-12       Impact factor: 4.790

View more
  5 in total

1.  Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.

Authors:  David H Adler; Melissa Wallace; Thola Bennie; Megan Mrubata; Beau Abar; Tracy L Meiring; Anna-Lise Williamson; Linda-Gail Bekker
Journal:  Infect Dis Obstet Gynecol       Date:  2014-10-20

Review 2.  Human Papilloma Virus self-sampling performance in low- and middle-income countries.

Authors:  Ashwini Kamath Mulki; Mellissa Withers
Journal:  BMC Womens Health       Date:  2021-01-06       Impact factor: 2.809

Review 3.  Prevalence and distribution of selected cervical human papillomavirus types in HIV infected and HIV uninfected women in South Africa, 1989-2021: A narrative review.

Authors:  Rixongile R Rikhotso; Emma M Mitchell; Daniel T Wilson; Aubrey Doede; Nontokozo D Matume; Pascal O Bessong
Journal:  S Afr J Infect Dis       Date:  2022-06-08

4.  Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa.

Authors:  Paul C Adamson; Megan J Huchko; Alison M Moss; Hans F Kinkel; Andrew Medina-Marino
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

Review 5.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.